EUVIMEDEUVIMED entdecken
Open Access

Cryo‐ EM structures of engineered Shiga toxin‐based immunogens capable of eliciting neutralizing antibodies with therapeutic potential against hemolytic uremic syndrome

Alejandro Ezequiel Cristófalo, Arvind Sharma, María Laura Cerutti, Kedar Sharma, Roberto Melero, Romina Pardo, Fernando Alberto Goldbaum, Mario Borgnia, Vanesa Zylberman, Lisandro Horacio Otero iD

Protein Science · 2025-06 · 34 (6)

DOI: 10.1002/pro.70178 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Protein Science, online erschienen am 24.05.2025. Verfasst von Alejandro Ezequiel Cristófalo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Rediseño e Ingeniería de Proteínas (CRIP), Escuela de Bio y Nanotecnologías (EByN), Universidad Nacional de San Martín (UNSAM), Consejo Nac…. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, Hemolytic-Uremic Syndrome, Shiga Toxin 2, Shiga Toxin 1. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: US National Institute Health Intramural Research Program: NIH Intramural Targeted Anti-COVID-19 Program, Intramural NIH HHS, Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Shiga toxin‐producing Escherichia coli ‐associated hemolytic uremic syndrome (STEC‐HUS) is a serious disease that causes renal failure predominantly in children. Despite its significant impact, there are currently no licensed vaccines or effective therapies available. The B subunits of Shiga toxins 1 and 2 (Stx1B and Stx2B) are suitable targets for developing neutralizing antibodies, but their pentameric assembly is unstable when isolated from the whole toxin. Taking advantage of the oligomeric symmetry shared between Stx1B and Stx2B with the lumazine synthase from Brucella spp. (BLS), we have previously engineered the chimeric toxoids BLS‐Stx1B and BLS‐Stx2B as immunogens to generate therapeutic equine polyclonal antibodies. The resulting product (INM004) has successfully passed Phases 1 and 2 clinical trials, and a Phase 3 has been launched in Argentina and seven European countries. In this work, we present the cryo‐electron microscopy structures of BLS‐Stx1B and BLS‐Stx2B, which confirm that these engineered immunogens effectively stabilize the StxB pentamers. Moreover, our results reveal that both chimeric constructs present high flexibility at their extremes, corresponding to motions of the StxBs with respect to the BLS core. Additionally, we present structural evidence of the interaction between the chimeras and polyclonal Fab (pFab) fragments derived from INM004, demonstrating that the elicited neutralizing antibodies block most of the interaction surface of the toxins with their cellular receptors. These findings further validate this promising antibody‐based therapy for mitigating STEC‐HUS and demonstrate that the BLS‐Stx1B and BLS‐Stx2B chimeras are potential candidates for developing a human vaccine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, NeutralizingHemolytic-Uremic SyndromeShiga Toxin 2Shiga Toxin 1Cryoelectron MicroscopyHumansAnimalsBrucellaProtein EngineeringShiga-Toxigenic Escherichia coliHorsesModels, Molecular

Stichwörter der Autor:innen

Brucella spp. lumazine synthase (BLS)F(ab′)2 fragmentsShiga toxin B subunits (Stx1B and Stx2B)Shiga‐toxin‐producing Escherichia coli (STEC)antiserumchimeracryo‐electron microscopyhemolytic uremic syndrome (HUS)hyperimmune horse seraprotein structuretreatmentvaccine

Substanzen

Antibodies, NeutralizingShiga Toxin 2Shiga Toxin 1

Autor:innen und Institutionen

  • Centro de Rediseño e Ingeniería de Proteínas (CRIP), Escuela de Bio y Nanotecnologías (EByN), Universidad Nacional de San Martín (UNSAM), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Gral. San M…
  • Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences (NIEHS), National Institute of Health (NIH), Research Triangle Park, North Carolina, USA.
  • Centro Nacional de Biotecnología (CNB), Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
  • Inmunova S.A, Gral. San Martín, Buenos Aires, Argentina.
  • Departamento de Biología Molecular, Facultad de Ciencias Exactas, Físico-Químicas y Naturales, Instituto de Biotecnología Ambiental y Salud (INBIAS), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET),…

ORCID-Profile: Lisandro Horacio Otero

Förderung

  • US National Institute Health Intramural Research Program: NIH Intramural Targeted Anti-COVID-19 Program
  • Intramural NIH HHS
  • Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación
  • US National Institute Health Intramural Research Program: US National Institutes of Environmental Health Sciences

Zitieren

APA

Cristófalo, A. E., Sharma, A., Cerutti, M. L., Sharma, K., Melero, R., Pardo, R., Goldbaum, F. A., Borgnia, M., Zylberman, V., & Otero, L. H. (2025). Cryo‐ EM structures of engineered Shiga toxin‐based immunogens capable of eliciting neutralizing antibodies with therapeutic potential against hemolytic uremic syndrome. Protein Science, 34(6). https://doi.org/10.1002/pro.70178

Vancouver

Cristófalo AE, Sharma A, Cerutti ML, Sharma K, Melero R, Pardo R, et al. Cryo‐ EM structures of engineered Shiga toxin‐based immunogens capable of eliciting neutralizing antibodies with therapeutic potential against hemolytic uremic syndrome. Protein Science. 2025;34(6). doi:10.1002/pro.70178

BibTeX
@article{Cristfalo2025,
  author = {Cristófalo, Alejandro Ezequiel and Sharma, Arvind and Cerutti, María Laura and Sharma, Kedar and Melero, Roberto and Pardo, Romina and Goldbaum, Fernando Alberto and Borgnia, Mario and Zylberman, Vanesa and Otero, Lisandro Horacio},
  title = {Cryo‐ EM structures of engineered Shiga toxin‐based immunogens capable of eliciting neutralizing antibodies with therapeutic potential against hemolytic uremic syndrome},
  journal = {Protein Science},
  year = {2025},
  volume = {34},
  number = {6},
  doi = {10.1002/pro.70178}
}
Kostenlos starten →